InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Xencor Inc

XNCR Clue Score24
United States Fiscal year ends December CIK 0001326732 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

37
Insider
Date
Role
Action
Shares
Price
Amount
Bassil I Dahiyat
19 Dec 2025
President & CEO
Sold after exercise
114,377
$15.71
$1.80M
John R Desjarlais
19 Dec 2025
Sr. Vice President & CSO
Sold after exercise
73,367
$15.72
$1.15M
Alan Bruce Montgomery
4 Dec 2024
Director
Sold after exercise
1,421
$27.03
$38.41K
Alan Bruce Montgomery
2 Dec 2024
Director
Sold after exercise
13,301
$27.03
$359.52K
Bassil I Dahiyat
21 Nov 2024
President & CEO
Sold after exercise
49,278
$24.07
$1.19M
Bassil I Dahiyat
13 Nov 2024
President & CEO
Sold after exercise
3,366
$24.02
$80.84K
John R Desjarlais
11 Nov 2024
Sr. Vice President & CSO
Sold after exercise
68,684
$23.48
$1.61M
John R Desjarlais
9 Jul 2024
Sr. Vice President & CSO
Sold after exercise
36,329
$18.32
$665.51K
Kurt A Gustafson
6 Mar 2024
Director
Sold after exercise
14,000
$23.18
$324.45K
John R Desjarlais
13 Feb 2024
Sr. Vice President & CSO
Sold after exercise
54,108
$19.38
$1.05M
Bassil I Dahiyat
29 Dec 2023
President & CEO
Sold after exercise
45,000
$20.93
$941.67K
Bassil I Dahiyat
21 Jun 2023
President & CEO
Sold after exercise
33,497
$26.19
$877.29K
John J Kuch
1 Mar 2021
Sr. Vice President & CFO
Sold after exercise
15,065
$48.90
$736.67K
John J Kuch
21 Aug 2019
Sr. Vice President & CFO
Sold after exercise
40,000
$41.27
$1.65M
Paul A Foster
17 Sep 2018
Chief Medical Officer
Sold after exercise
40,000
$46.03
$1.84M
Paul A Foster
17 Aug 2018
Chief Medical Officer
Sold after exercise
3,659
$40.10
$146.73K
Paul A Foster
16 Aug 2018
Chief Medical Officer
Sold after exercise
20,739
$41.10
$852.37K
Paul A Foster
15 Aug 2018
Chief Medical Officer
Sold after exercise
106
$41.10
$4.36K
Paul A Foster
14 Aug 2018
Chief Medical Officer
Sold after exercise
15,496
$41.11
$636.98K
Edgardo Baracchini Jr
13 Aug 2018
Chief Business Officer
Sold after exercise
12,734
$40.35
$513.87K
John R Desjarlais
9 Aug 2018
Sr. V.P., Research & CSO
Sold after exercise
20,133
$40.61
$817.63K
Edgardo Baracchini Jr
9 Aug 2018
Chief Business Officer
Sold after exercise
8,283
$40.35
$334.20K
Bassil I Dahiyat
15 Jun 2018
President and CEO
Sold after exercise
50,000
$40.51
$2.03M
John J Kuch
13 Jun 2018
Sr. Vice President & CFO
Sold after exercise
25,000
$41.64
$1.04M
Edgardo Baracchini Jr
15 Mar 2018
Chief Business Officer
Sold after exercise
40,000
$30.89
$1.24M
Edgardo Baracchini Jr
5 Mar 2018
Chief Business Officer
Sold after exercise
10,000
$29.58
$295.84K
Edgardo Baracchini Jr
2 Mar 2018
Chief Business Officer
Sold after exercise
10,000
$29.60
$295.97K
Edgardo Baracchini Jr
27 Feb 2018
Chief Business Officer
Sold after exercise
20,000
$29.64
$592.85K
Paul A Foster
22 Feb 2018
Chief Medical Officer
Sold after exercise
10,000
$26.03
$260.30K
Edgardo Baracchini Jr
22 Feb 2018
Chief Business Officer
Sold after exercise
8,069
$26.00
$209.79K
Paul A Foster
16 Feb 2018
Chief Medical Officer
Sold after exercise
5,000
$25.01
$125.05K
Edgardo Baracchini Jr
2 May 2017
Chief Business Officer
Sold after exercise
750
$26.07
$19.55K
Edgardo Baracchini Jr
1 May 2017
Chief Business Officer
Sold after exercise
9,818
$26.01
$255.37K
Edgardo Baracchini Jr
27 Apr 2017
Chief Business Officer
Sold after exercise
904
$26.04
$23.54K
John J Kuch
16 Mar 2017
Vice President, Finance
Sold after exercise
15,000
$24.42
$366.28K
Edgardo Baracchini Jr
8 Mar 2017
Chief Business Officer
Sold after exercise
1,821
$25.00
$45.53K
John R Desjarlais
5 Dec 2016
Sr. V.P., Research & CSO
Sold after exercise
45,000
$26.57
$1.20M
Show all 189 transactions →

What was left out

Form 4 filings counted 241
Amendments (4/A) skipped 9
Filings about a different issuer 2
Unreadable filings 0
Joint filings 21
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 37
Sales at will 96
Transactions with no price 0
Shares from compensation/vesting 2,551,915
Sales filed before the plan box existed 64
History held since 6 Dec 2013